Neurology Central

Gene therapy for Rett syndrome: prospects and challenges


Rett syndrome (RTT) is a neurological disorder that affects females and is caused by loss-of-function mutations in the X-linked gene MECP2. Deletion of Mecp2 in mice results in a constellation of neurological features that resemble those seen in RTT patients. Experiments in mice have demonstrated that restoration of MeCP2, even at adult stages, reverses several aspects of the RTT-like pathology suggesting that the disorder may be inherently treatable.

Restricted Content / Members Only

You cannot view this content because It is available to members only. Please or Register to view this area.